Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

  1. Castañón, E.
  2. Rolfo, C.
  3. Viñal, D.
  4. López, I.
  5. Fusco, J.P.
  6. Santisteban, M.
  7. Martin, P.
  8. Zubiri, L.
  9. Echeveste, J.I.
  10. Gil-Bazo, I.
Revista:
Journal of Translational Medicine

ISSN: 1479-5876

Any de publicació: 2015

Volum: 13

Número: 1

Tipus: Article

DOI: 10.1186/S12967-015-0622-X GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus